Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_assertion type Assertion NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_head.
- NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_assertion description "[The United States CF Foundation recently proposed the term cystic fibrosis transmembrane conductance regulator related metabolic syndrome (CRMS) to describe infants with elevated immunoreactive trypsinogen (IRT) on NBS who do not meet diagnostic criteria for CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_provenance.
- NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_assertion evidence source_evidence_literature NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_provenance.
- NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_assertion SIO_000772 21538969 NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_provenance.
- NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_assertion wasDerivedFrom befree-20140225 NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_provenance.
- NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_assertion wasGeneratedBy ECO_0000203 NP697704.RACzkCnSL72RslE2m9edpZqK0S5XS3StKuY7BCqABUnfY130_provenance.